Table 1. Lung cancer distribution by histology and staging.
Author | N | Type of facility | NSCLC, % | SCC/Ad ratio | III-IV, % |
---|---|---|---|---|---|
Ismael et al.( 18 ) | 1,887 | Public | 89 | 0.93 | 71 |
Younes et al.( 19 ) | 737 | Public | 100a | 1.20 | 74 |
Westphal et al.( 20 ) | 352 | Public | 91 | 2.54 | 66 |
Barros et al.( 21 ) | 263 | Public | 87 | 1.96 | 94 |
Novaes et al.( 22 ) | 240 | Public | 80 | 1.25 | 72 |
Araujo et al.( 23 ) | 566 | Private | 100a | 0.33 | 80 |
Caires-Lima et al.( 26 ) | 232 | Public | 92 | 0.48 | 93 |
Mascarenhas et al.( 24 ) | 338 | Private | 83 | 0.38 | 78 |
Freitas et al.( 25 ) | 93 | Private | 100a | 0.33 | 88 |
NSCLC: non-small cell lung cancer cases; SCC: squamous cell carcinoma cases; Ad: adenocarcinoma cases; and III-IV: patients in stages III or IV. aStudies including only NSCLC cases.